Hiroshi Sunada
Papers
3
Total Citations
26
H-Index
2
About
Dr. Hiroshi Sunada is a leading urologic surgeon and researcher whose work centers on optimizing surgical outcomes for patients undergoing robot-assisted radical cystectomy (RARC) for bladder cancer. His primary research areas include the comparative effectiveness of different urinary diversion techniques—specifically intracorporeal, extracorporeal, and hybrid ileal conduit methods—and the impact of patient age on surgical success. Dr. Sunada’s major contributions stem from a landmark nationwide multi-institutional study in Japan, which provided robust, propensity score-matched evidence that intracorporeal urinary diversion offers superior perioperative outcomes and fewer complications compared to extracorporeal or hybrid approaches. This work, cited 13 times, has directly influenced surgical practice by guiding the choice of diversion technique. Additionally, his research demonstrated that septuagenarian patients can achieve comparable peri-operative efficacy and long-term survival benefits to younger patients after RARC, challenging age-based surgical biases. With over 26 citations across his most influential papers, Dr. Sunada’s findings are shaping evidence-based guidelines in robotic urologic oncology, highlighting his role as a key figure in advancing minimally invasive bladder cancer surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3